Chen Weijie, Lu Shuiping, Xiong Haiyan, Xiang Zhiyu, Wang Yuxi, Hu Jingjing, Pan Yue, Li Yanjiao, Gao Qile, Chen Qi, Hu Siru, Wang Weibing, Xiong Chenglong
School of Public Health, Fudan University, Key Lab of Public Health Safety, Ministry of Education, Shanghai 200433, China.
Department of Clinical Medicine, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Virol Sin. 2025 Feb;40(1):15-23. doi: 10.1016/j.virs.2024.12.002. Epub 2024 Dec 18.
On January 30, 2024, China announced the first human case of H10N5 influenza infection. Prior to this, human cases of H10N7 and H10N8 had been reported. It is now appropriate to re-examine the evolution and future epidemiological trends of the H10 and N5 subtypes of avian influenza viruses (AIVs). In this study, we analyzed the reassortment characteristics of the first human-derived H10N5 AIV (A/Zhejiang/ZJU01/2023), as well as the evolutionary dynamics of the wild bird-derived H10 and N5 subtypes of AIVs over the past decade. Our findings indicate that the human-derived H10N5 AIV exhibited low pathogenicity. A/bean_goose/Korea/KNU-10/2022(H10N7) and A/mallard/Novosibirsk_region/962k/2018(H12N5) were identified as the potential reassortment parents. The virus has existed since 2022 and several isolations have been reported in Bangladesh. Phylogenetic analysis showed that H10Ny and HxN5 AIVs in China are clustered differently based on the East Asian-Australian (eastern) and Central Asian-Indian (western) migratory flyways. The H10Ny and HxN5 AIV reassortant strains may cause human infections through accidental spillover. It is possible that another center of AIV evolution, mutation, and reassortment may be developing along the migratory flyways in northeastern Asia, distinct from Europe, the Americas, and China's Yangtze River Delta and Pearl River Delta, which should be closely monitored to ensure the safety of the public.
2024年1月30日,中国报告了首例人感染H10N5禽流感病例。在此之前,曾有H10N7和H10N8人感染病例的报道。现在有必要重新审视甲型流感病毒(AIV)H10和N5亚型的进化及未来流行病学趋势。在本研究中,我们分析了首例源自人类的H10N5 AIV(A/浙江/ZJU01/2023)的重配特征,以及过去十年源自野生鸟类的AIV H10和N5亚型的进化动态。我们的研究结果表明,源自人类的H10N5 AIV表现出低致病性。A/豆雁/韩国/KNU - 10/2022(H10N7)和A/绿头鸭/新西伯利亚地区/962k/2018(H12N5)被确定为潜在的重配亲本。该病毒自2022年以来就已存在,孟加拉国已报告了多起分离株。系统发育分析表明,中国的H10Ny和HxN5 AIVs根据东亚 - 澳大利亚(东部)和中亚 - 印度(西部)候鸟迁徙路线聚类不同。H10Ny和HxN5 AIV重配株可能通过意外溢出导致人类感染。在亚洲东北部的候鸟迁徙路线沿线,可能正在形成一个与欧洲、美洲以及中国长江三角洲和珠江三角洲不同的AIV进化、突变和重配中心,应密切监测以确保公众安全。